Inhibikase Therapeutics, Inc. reports leadership or board changes

Inhibikase Therapeutics, Inc. filed an 8-K covering director or executive-officer changes and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.